Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FY22Q
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,274
Award facts
- Contract value 100% obligated
- $4,274.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on August 7, 2025, for Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $4,274.13. The delivery order, which carries no set-aside designation, is set for ultimate completion on August 8, 2025, with performance to be executed at the contractor's Park Ridge location. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities worldwide.
Eliquis is a widely prescribed anticoagulant medication used in Department of Defense healthcare systems for thromboembolic prevention and treatment. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for contracts with the DLA. The company's extensive portfolio of federal contract awards demonstrates its capacity to distribute branded and generic prescription drugs, biologics, and medical consumables across the military health system. This delivery order exemplifies the routine pharmaceutical procurement operations conducted through the SPE2DB program to ensure uninterrupted medication availability at military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FY22Q?
SPE2DB25FY22Q was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FY22Q worth?
The government has obligated $4,274 on SPE2DB25FY22Q.
Is contract SPE2DB25FY22Q an order under another contract?
Yes. SPE2DB25FY22Q is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY22Q competed?
The extent of competition for SPE2DB25FY22Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award